Is CyberArk The Next Big Cybersecurity Stock?
CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…
Buy
51
LMAT Quote, Financials, Valuation and Earnings
Last price:
$84.98
Seasonality move
:
12.95%
Day range:
$81.95 - $85.51
52-week range:
$62.39 - $109.58
Dividend yield:
0.8%
P/E ratio:
43.87x
P/S ratio:
8.81x
P/B ratio:
5.69x
Volume:
333.3K
Avg. volume:
239.7K
1-year change:
27.33%
Market cap:
$1.9B
Revenue:
$219.9M
EPS (TTM):
$1.94
LeMaitre Vascular Number of Institutional Trades
LeMaitre Vascular Volume of Institutional Trades
Amount of Institutions Buying
--
(Last Month)
Amount of Institutional Buying
$3.2B
(Last 6 Months)
Current Institutional Ownership Percentage
--
Amount of Institutions Selling
--
(Last Month)
Amount of Institutional Selling
$1.3B
(Last 6 Months)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
LeMaitre Vascular Institutional Ownership
-
What Percentage Of LMAT Is Owned by Institutions?
-- of LMAT is owned by institutions.
-
How Many Institutions Own LMAT Shares?
LeMaitre Vascular stock is owned by 579 institutional shareholders at this time.
-
Have Institutions Been Buying LMAT Stock?
Yes, institutions have bought 21.3M shares of LMAT in the last quarter.
-
Have Institutions Been Selling LMAT Stock?
Yes, institutions have sold 7.8M shares of LMAT over the last quarter.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is the Market Going to Go Lower?
The last month has been extremely difficult for the stock…
2 Dividend Stocks to Buy in a Recession
While many economists and investors initially expected 2025 to be…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
54
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 41x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Buy
52
RGC alert for Mar 18
Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.
Buy
63
EXOD alert for Mar 18
Exodus Movement [EXOD] is down 3.96% over the past day.
Sell
45
MNPR alert for Mar 18
Monopar Therapeutics [MNPR] is up 0.93% over the past day.
